Depression, anemia and health-related quality of life in chronic hepatitis C

Journal of Hepatology

Volumn 44, Issue 3, 2006, Pages 491-498

  Dan, Amy A ^a   Martin, Lisa M ^a   Crone, Cathy ^a   Ong, Janus P ^a   Farmer, Denise W ^a   Wise, Thomas ^a   Robbins, Sean C ^b   Younossi, Zobair M ^a  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b AMGEN INC   (United States)

Author keywords

Anemia; Depression; HCV; HRQL

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLISM; ANEMIA; ARTICLE; BODY MASS; CAUCASIAN; DEMOGRAPHY; DEPRESSION; DRUG BLOOD LEVEL; FEMALE; HEPATITIS C; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RACE DIFFERENCE; RATING SCALE; SEX DIFFERENCE; SEX RATIO; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA; ANTIVIRAL AGENTS; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RIBAVIRIN; RISK FACTORS;

EID: 32444441241     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.11.046     Document Type: Article

References (21)

1. W.R. Kim, R.S. Brown Jr, N.A. Terrault, and H. El-Serag Burden of liver disease in the United States: summary of a workshop Hepatology 36 2002 227 242
2. H.I. Bonkovsky, and J.M. Woolley Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group Hepatology 29 1999 264 270
3. J.E. Ware Jr, M.S. Bayliss, M. Mannocchia, and G.L. Davis Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group Hepatology 30 1999 550 555
4. M.R. Kraus, A. Schäfer, M. Psych, H. Faller, H. Csef, and M. Scheurlen Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy J Clin Psychiatry 64 2003 708 714
5. Z. Younossi, N. Boparai, M. McCormick, L.L. Price, and G. Guyatt Assessment of utilities and health-related quality of life in patients with chronic liver disease Am J Gastroentrol 96 2001 579 583
6. W. Hauser, C. Zimmer, P. Schiedermaier, and D. Grandt Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C Psychosom Med 66 2004 954 958
7. B.M. Spiegel, Z.M. Younossi, R.D. Hays, D. Revicki, and S Robbins Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment Hepatology 41 2005 790 800
8. D. Bernstein, L. Kleinman, C.M. Barker, D.A. Revicki, and J. Green Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients Hepatology 35 2002 704 708
9. M.R. Kraus, A. Schäfer, H. Csef, H. Faller, H. Mork, and M. Scheurlen Compliance with therapy in patients with chronic hepatitis C. Associations with psychiatric symptoms, interpersonal problems, and mode of acquisition Dig Dis Sci 46 2001 2060 2065
10. N.H. Afdhal Role of epoetin alfa in maintaining ribavirin dose Gastroenterol Clin North Am 33 2004 S25 S35
11. P.J. Pockros, M.L. Shiffman, E.R. Schiff, M.S. Sulkowski, Z. Younossi, and D.T. Dieterich Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy Hepatology 40 2004 1450 1458
12. Z.M. Younossi, A.C. McCullough, D.S. Barnes, A. Post, J.P. Ong, and R. O'Shea Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C Dig Dis Sci 50 2005 970 975
13. M. Tod, M. Farcy-Afif, J. Stocco, N. Boyer, V. Bouton, and M. Sinegre Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C Clin Pharmacokinet 44 2005 417 428
14. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1993.
15. M.P. Neary, S. Cort, M.S. Bayliss, and J.E. Ware Jr Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients Semin Liver Dis 19 1999 77 85
16. Z.M. Younossi, G. Guyatt, M. Kiwi, N. Bopari, and D. King Development of a disease specific questionnaire to measure health-related quality of life in patients with chronic liver disease Gut 45 1999 295 300
17. Z. Younossi, N. Boparai, L.L. Price, M.L. Kiwi, M. McCormick, and G. Guyatt Health-related quality of life in chronic liver disease: the impact of type and severity of disease Am J Gatroenterol 96 2001 2199 2205
18. L. Radloff The CES-D scale: a self-report depressive scale for research in the general population Appl Psychol Meas 1 1977 385 401
19. C.H. Clark, J.S. Mahoney, D.J. Clark, and L.R. Eriksen Screening for depression in a hepatitis C population: the reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D) J Adv Nurs 40 2002 361 369
20. T. Poynard, P. Cacoub, V. Ratziu, R.P. Myers, M.H. Dezailles, and A. Mercadier Fatigue in patients with hepatitis C J Viral Hepat 9 2002 295 303
21. J.G. McHutchison, J.E. Ware Jr, M.S. Bayliss, S. Pianko, J.K. Albrecht, and S. Cort The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity J Hepatology 34 2001 140 147